Inactive Instrument
Genex Pharmaceutical, Inc. Stock Other OTC
Stocks
GENX
US37227T1051
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 268K 232K 218K 199K 376K 25.5M 381K 2.54M 999K 12.74M 1.01M 983K 42.41M | P/E 2006 |
3.75x | P/E 2007 | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 413K 358K 335K 307K 579K 39.3M 586K 3.92M 1.54M 19.63M 1.55M 1.52M 65.35M | EV / Sales 2006 |
0.95x | EV / Sales 2007 | 1.6x |
| Free-Float |
99.62% | Yield 2006 * |
-
| Yield 2007 | - |
| 1 day | -4.55% |
| Manager | Title | Age | Since |
|---|---|---|---|
Fuzhi Song
CEO | Chief Executive Officer | 72 | - |
Shuli Zhang
DFI | Director of Finance/CFO | 72 | 2010-02-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Fuzhi Song
CHM | Chairman | 72 | 2010-02-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.55% | -39.83% | - | - | 1.78K | |
| +0.12% | -3.05% | -10.00% | +18.93% | 129B | |
| -0.95% | -7.58% | -17.91% | -2.53% | 12.56B | |
| +0.04% | +1.47% | +93.23% | +129.76% | 10.08B | |
| -2.47% | -4.82% | -44.21% | -69.67% | 4.7B | |
| -0.32% | -2.10% | -17.06% | +36.44% | 2.63B | |
| -12.82% | -10.20% | +2.14% | -55.58% | 1.74B | |
| -2.00% | +17.73% | -24.93% | -78.75% | 1.74B | |
| -1.64% | -1.37% | -17.11% | -19.73% | 1.67B | |
| Average | -2.73% | -1.17% | -4.48% | -5.14% | 20.55B | |
| Weighted average by Cap. | -0.22% | -2.99% | -5.47% | +19.63% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 2.44M 2.12M 1.98M 1.81M 3.42M 232M 3.47M 23.18M 9.1M 116M 9.15M 8.96M 386M | 3.24M 2.81M 2.63M 2.41M 4.54M 308M 4.6M 30.77M 12.08M 154M 12.15M 11.89M 513M |
| Net income | 619K 537K 503K 460K 869K 58.96M 880K 5.88M 2.31M 29.46M 2.32M 2.27M 98.05M | 343K 297K 278K 255K 481K 32.63M 487K 3.26M 1.28M 16.3M 1.29M 1.26M 54.26M |
| Net Debt | -0.19 -0.17 -0.16 -0.14 -0.27 -18.31 -0.27 -1.83 -0.72 -9.15 -0.72 -0.71 -30.45 | 0.14 0.13 0.12 0.11 0.2 13.8 0.21 1.38 0.54 6.89 0.54 0.53 22.95 |
Employees
-
